4.6 Letter

Voxelotor treatment of a patient with sickle cell disease and very severe anemia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Medical Laboratory Technology

Voxelotor (GBT440) produces interference in measurements of hemoglobin S

Nicola J. Rutherford et al.

CLINICA CHIMICA ACTA (2018)

Article Chemistry, Medicinal

Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin

Brian Metcalf et al.

ACS MEDICINAL CHEMISTRY LETTERS (2017)

Article Hematology

Treating sickle cell disease by targeting HbS polymerization

William A. Eaton et al.